Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Total knee arthroplasty (TKA) is frequently associated with significant postoperative pain, which may delay early mobilization and negatively affect functional recovery. Peripheral nerve blocks are widely used as part of multimodal analgesia strategies to improve postoperative pain control while minimizing opioid consumption and preserving motor function. Different peripheral nerve block techniques may result in varying analgesic efficacy and mobilization outcomes.
The aim of this prospective observational study is to compare the effects of commonly used peripheral nerve block techniques on postoperative pain control and early mobilization in patients undergoing total knee arthroplasty under spinal anesthesia. Patients receiving fascia iliaca plane block are compared with those receiving a combination of adductor canal block and interspace between the popliteal artery and capsule of the knee (IPACK) block.
The primary outcome is postoperative opioid consumption within the first 24 hours after surgery. Secondary outcomes include postoperative pain scores assessed at predefined time intervals, early mobilization parameters, and opioid-related adverse effects. The findings of this study are intended to contribute to optimizing analgesic strategies and improving early functional recovery following total knee arthroplasty.
Total knee arthroplasty (TKA) is a commonly performed orthopedic procedure associated with moderate to severe postoperative pain that may impair early mobilization and delay rehabilitation. Effective postoperative analgesia is essential to facilitate early functional recovery, reduce opioid consumption, and minimize postoperative complications. Multimodal analgesia strategies incorporating peripheral nerve blocks have become increasingly important in postoperative pain management following TKA.
Peripheral nerve block techniques aim to provide effective analgesia while preserving motor function to support early ambulation. Traditional proximal blocks may provide adequate pain relief but can be associated with motor weakness that limits mobilization. More distal techniques, such as the adductor canal block, are increasingly preferred due to their motor-sparing characteristics. The interspace between the popliteal artery and capsule of the knee (IPACK) block has been introduced to improve posterior knee analgesia without affecting motor function. The fascia iliaca plane block represents another commonly used regional anesthesia technique; however, comparative clinical data regarding analgesic efficacy and mobilization outcomes between these approaches remain limited.
This prospective observational study is conducted in patients undergoing unilateral total knee arthroplasty under spinal anesthesia. Participants receive either fascia iliaca plane block or a combination of adductor canal block and IPACK block as part of routine clinical practice. The study evaluates postoperative outcomes during the first 24 hours following surgery.
The primary objective is to compare total opioid consumption within the first 24 postoperative hours between the two peripheral nerve block techniques. Secondary objectives include assessment of postoperative pain intensity using the Numeric Rating Scale (NRS) at predefined time points, evaluation of early mobilization parameters, and comparison of opioid-related adverse effects.
Pain assessments are performed at 0, 2, 6, 12, and 24 hours postoperatively. Early mobilization is evaluated using standardized functional assessments, including walking ability and motor function tests of quadriceps and ankle dorsiflexor muscles. All patients receive standardized spinal anesthesia and postoperative patient-controlled analgesia to ensure comparable perioperative management.
The results of this study are expected to provide clinical evidence regarding the comparative effectiveness of commonly used peripheral nerve block techniques and to support optimization of postoperative analgesia protocols aimed at improving recovery after total knee arthroplasty.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Fascia Iliaca Plane Block | Participants in this cohort receive an ultrasound-guided fascia iliaca plane block prior to surgery as part of routine perioperative analgesia. The block is performed under sterile conditions using an in-plane technique with a high-frequency linear ultrasound probe. A total volume of 40 mL of 0.25% bupivacaine is administered within the fascia iliaca compartment. All patients undergo spinal anesthesia for total knee arthroplasty and receive standardized postoperative patient-controlled analgesia. |
| |
| Adductor Canal + IPACK Block | Participants in this cohort receive a combination of ultrasound-guided adductor canal block and interspace between the popliteal artery and capsule of the knee (IPACK) block prior to surgery as part of routine perioperative analgesia. The adductor canal block is performed with 20 mL of 0.25% bupivacaine, followed by an IPACK block using 20 mL of 0.25% bupivacaine under ultrasound guidance. All patients undergo spinal anesthesia for total knee arthroplasty and receive standardized postoperative patient-controlled analgesia. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Fascia Iliaca Plane Block | Procedure | Ultrasound-guided fascia iliaca plane block is performed under sterile conditions prior to surgery as part of perioperative analgesia. Using an in-plane technique with a high-frequency linear ultrasound probe, the needle is advanced beneath the fascia iliaca, and 40 mL of 0.25% bupivacaine is injected incrementally after negative aspiration to achieve spread within the fascia iliaca compartment. |
| Measure | Description | Time Frame |
|---|---|---|
| Total Postoperative Opioid Consumption | Total opioid consumption administered via patient-controlled analgesia (PCA) during the first 24 hours following total knee arthroplasty. Opioid use is recorded as the cumulative dose of morphine (mg) delivered by the PCA device. | Within the first 24 hours after surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Postoperative Pain Intensity (NRS Score) | Postoperative pain intensity assessed using the Numeric Rating Scale (NRS), where 0 indicates no pain and 10 indicates the worst imaginable pain. Pain scores are recorded at predefined postoperative time points under resting conditions. | 0, 2, 6, 12, and 24 hours after surgery |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
The study population consists of adult patients undergoing elective unilateral total knee arthroplasty at a tertiary care hospital. Eligible participants include patients receiving spinal anesthesia and perioperative peripheral nerve block analgesia as part of routine clinical practice. The population represents individuals undergoing primary knee replacement surgery for degenerative joint disease who are suitable for early postoperative mobilization and standardized postoperative pain management protocols.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| SBU Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital | Ankara | 06200 | Turkey (Türkiye) |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 34653576 | Background | Mou P, Wang D, Tang XM, Zeng WN, Zeng Y, Yang J, Zhou ZK. Adductor Canal Block Combined With IPACK Block for Postoperative Analgesia and Function Recovery Following Total Knee Arthroplasty: A Prospective, Double-Blind, Randomized Controlled Study. J Arthroplasty. 2022 Feb;37(2):259-266. doi: 10.1016/j.arth.2021.10.004. Epub 2021 Oct 13. | |
| 35157136 |
Not provided
Not provided
Individual participant data collected during this study will not be made publicly available. De-identified data may be shared upon reasonable request to the corresponding author, subject to institutional approval and applicable ethical and legal regulations.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Adductor Canal Block + IPACK Block | Procedure | An ultrasound-guided adductor canal block followed by an interspace between the popliteal artery and capsule of the knee (IPACK) block is performed prior to surgery as part of perioperative analgesia. The adductor canal block is administered using 20 mL of 0.25% bupivacaine injected adjacent to the femoral artery beneath the sartorius muscle. Subsequently, the IPACK block is performed with 20 mL of 0.25% bupivacaine injected into the tissue plane between the popliteal artery and the posterior capsule of the knee under ultrasound guidance. |
|
| Early Mobilization Performance |
Early postoperative mobilization assessed using standardized functional evaluations, including walking ability, quadriceps muscle strength, and ankle dorsiflexor motor function scores recorded at postoperative assessment. |
| 24 hours after surgery |
| Et T, Korkusuz M, Basaran B, Yarimoglu R, Toprak H, Bilge A, Kumru N, Dedeli I. Comparison of iPACK and periarticular block with adductor block alone after total knee arthroplasty: a randomized clinical trial. J Anesth. 2022 Apr;36(2):276-286. doi: 10.1007/s00540-022-03047-6. Epub 2022 Feb 14. |
| 32694032 | Background | Kertkiatkachorn W, Kampitak W, Tanavalee A, Ngarmukos S. Adductor Canal Block Combined With iPACK (Interspace Between the Popliteal Artery and the Capsule of the Posterior Knee) Block vs Periarticular Injection for Analgesia After Total Knee Arthroplasty: A Randomized Noninferiority Trial. J Arthroplasty. 2021 Jan;36(1):122-129.e1. doi: 10.1016/j.arth.2020.06.086. Epub 2020 Jul 2. |
| ID | Term |
|---|---|
| D010149 | Pain, Postoperative |
| D000377 | Agnosia |
| ID | Term |
|---|---|
| D011183 | Postoperative Complications |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D010468 | Perceptual Disorders |
| D019954 | Neurobehavioral Manifestations |
| D009422 | Nervous System Diseases |
Not provided
Not provided